1. Clinical Experience with the Cervista HPV HR Assay
Kenneth E. Youens, Gregory A. Hosler, Paula J. Washington, E. Patrick Jenevein, Kathleen M. Murphy 
The Journal of Molecular Diagnostics 
Volume 13, Issue 2, Pages (March 2011)
DOI: /j.jmoldx
Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

2. Figure 1
Percent HR-HPV positive by cytologic interpretation. A: All samples. B: ASC-US. C: Women aged 30 years or older, NILM. All calculations are for reportable samples only. Whiskers indicate 95% confidence intervals.
The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx )
Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

3. Figure 2
HR-HPV positivity rates, stratified by age, for women aged 30 years or older with NILM cytologic interpretations, United States studies. Whiskers indicate 95% confidence intervals. *Reported in intervals of 10 years (ie, 30–39, 40–49, ≥50).
The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx )
Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions